|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Domper Arnal MJ, Ferrández Arenas Á and
Lanas Arbeloa Á: Esophageal cancer: Risk factors, screening and
endoscopic treatment in Western and Eastern countries. World J
Gastroenterol. 21:7933–7943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ide H, Nakamura T, Hayashi K, Endo T,
Kobayashi A, Eguchi R and Hanyu F: Esophageal squamous cell
carcinoma: Pathology and prognosis. World J Surg. 18:321–330. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuda S, Takeuchi H, Kawakubo H, Ando N
and Kitagawa Y: Current advancement in multidisciplinary treatment
for resectable cStage II/III esophageal squamous cell carcinoma in
Japan. Ann Thorac Cardiovasc Surg. 22:275–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watanabe M, Otake R, Kozuki R, Toihata T,
Takahashi K, Okamura A and Imamura Y: Correction to: Recent
progress in multidisciplinary treatment for patients with
esophageal cancer. Surg Today. 50:4252020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shah MA, Kojima T, Hochhauser D, Enzinger
P, Raimbourg J, Hollebecque A, Lordick F, Kim SB, Tajika M, Kim HT,
et al: Efficacy and safety of pembrolizumab for heavily pretreated
patients with advanced, metastatic adenocarcinoma or squamous cell
carcinoma of the esophagus: The phase 2 KEYNOTE-180 study. JAMA
Oncol. 5:546–550. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kojima T, Shah MA, Muro K, Francois E,
Adenis A, Hsu CH, Doi T, Moriwaki T, Kim SB, Lee SH, et al:
Randomized phase III KEYNOTE-181 study of pembrolizumab versus
chemotherapy in advanced esophageal cancer. J Clin Oncol.
38:4138–4148. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sudo T, Nishida R, Kawahara A, Saisho K,
Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, et al:
Clinical impact of tumor-infiltrating lymphocytes in esophageal
squamous cell carcinoma. Ann Surg Oncol. 24:3763–3770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohtani H: Focus on TILs: Prognostic
significance of tumor infiltrating lymphocytes in human colorectal
cancer. Cancer Immun. 7:42007.PubMed/NCBI
|
|
10
|
Huh JW, Lee JH and Kim HR: Prognostic
significance of tumor-infiltrating lymphocytes for patients with
colorectal cancer. Arch Surg. 147:366–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang WB, Seo NA, Yoon S, Bae HI, Jeon SW,
Kwon OK, Chung HY, Yu W, Kang H and Kim JG: Prognostic value of
tumor-infiltrating lymphocytes in Epstein-Barr virus-associated
gastric cancer. Ann Oncol. 27:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang D, He W, Wu C, Tan Y, He Y, Xu B,
Chen L, Li Q and Jiang J: Scoring system for tumor-infiltrating
lymphocytes and its prognostic value for gastric cancer. Front
Immunol. 10:712019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu G, Chen L, Wu S, Feng Y and Lin T:
Comprehensive analysis of tumor-infiltrating immune cells and
relevant therapeutic strategy in esophageal cancer. Dis Markers.
2020:89747932020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giannakis M, Mu JX, Shukla AS, Qian ZR,
Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et
al: Genomic correlates of immune-cell infiltrates in colorectal
carcinoma. Cell Rep. 15:857–865. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tahara H, Shiozaki H, Kobayashi K, Yano T,
Yano H, Tamura S, Oku K, Miyata M, Wakasa K, Sakurai M, et al:
Phenotypic characteristics of tumour. infiltrating lymphocytes in
human oesophageal cancer tissues defined by quantitative two-colour
analysis with flow-cytometry. Virchows Arch A Pathol Anat
Histopathol. 416:329–334. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Woo EY, Yeh H, Chu CS, Schlienger K,
Carroll RG, Riley JL, Kaiser LR and June CH: Cutting edge:
Regulatory T cells from lung cancer patients directly inhibit
autologous T cell proliferation. J Immunol. 168:4272–4276. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ostrand-Rosenberg S: Immune surveillance:
A balance between protumor and antitumor immunity. Curr Opin Genet
Dev. 18:11–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heilig SJ and Tonegawa S: Diversity of
murine gamma genes and expression in fetal and adult T lymphocytes.
Nature. 322:836–840. 1986. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Postow MA, Manuel M, Wong P, Yuan J, Dong
Z, Liu C, Perez S, Tanneau I, Noel M, Courtier A, et al: Peripheral
T cell receptor diversity is associated with clinical outcomes
following ipilimumab treatment in metastatic melanoma. J Immunother
Cancer. 3:232015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cha E, Klinger M, Hou Y, Cummings C, Ribas
A, Faham M and Fong L: Improved survival with T cell clonotype
stability after anti-CTLA-4 treatment in cancer patients. Sci
Transl Med. 6:238ra702014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robert L, Tsoi J, Wang X, Emerson R, Homet
B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, et al:
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Clin Cancer Res. 20:2424–2432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Zhang Y, Zhang C, Chen J, Lou X,
Chen X, Kang L, Xu N, Li M, Tan J, et al: Comparation of CART19 and
autologous stem-cell transplantation for refractory/relapsed
non-Hodgkin's lymphoma. JCI Insight. 5:e1301952019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu K, Kang N, Liu Y, Guo D, Jing W, Lu J,
Tan T, Lv C, Deng Y, Long J, et al: Proposed revision of N
categories to the 8th edition of the AJCC-TNM staging system for
non-surgical esophageal squamous cell cancer. Cancer Sci.
110:717–725. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schneider AC, Rasband SW and Eliceiri WK:
NIH image to imageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamaguchi-Kabata Y, Nakazono K, Takahashi
A, Saito S, Hosono N, Kubo M, Nakamura Y and Kamatani N: Japanese
population structure, based on SNP genotypes from 7003 individuals
compared to other ethnic groups: Effects on population-based
association studies. Am J Hum Genet. 83:445–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armstrong SA, Staunton JE, Silverman LB,
Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR
and Korsmeyer SJ: MLL translocations specify a distinct gene
expression profile that distinguishes a unique leukemia. Nat Genet.
30:41–47. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsutani T, Yoshioka T, Tsuruta Y,
Iwagami S and Suzuki R: Analysis of TCRAV and TCRBV repertoires in
healthy individuals by microplate hybridization assay. Hum Immunol.
56:57–69. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitaura K, Shini T, Matsutani T and Suzuki
R: A new high-throughput sequencing method for determining
diversity and similarity of T cell receptor (TCR) α and β
repertoires and identifying potential new invariant TCR α chains.
BMC Immunol. 17:382016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McCarthy JD, Chen Y and Smyth KG:
Differential expression analysis of multifactor RNA-Seq experiments
with respect to biological variation. Nucleic Acids Res.
40:4288–4297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robinson DM, McCarthy JD and Smyth KG:
EdgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bolen CR, Rubelt F, Vander Heiden JA and
Davis MM: The repertoire dissimilarity index as a method to compare
lymphocyte receptor repertoires. BMC Bioinformatics. 18:1552017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rubelt F, Bolen CR, McGuire HM, Vander
Heiden JA, Gadala-Maria D, Levin M, Euskirchen GM, Mamedov MR, Swan
GE, Dekker CL, et al: Individual heritable differences result in
unique cell lymphocyte receptor repertoires of naive and
antigen-experienced cells. Nat Commun. 7:111122016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carreno MB, Magrini V, Becker-Hapak M,
Kaabinejadian S, Hundal J, Petti AA, Ly A, Lie WR, Hildebrand WH,
Mardis ER and Linette GP: Cancer immunotherapy. A dendritic cell
vaccine increases the breadth and diversity of melanoma
neoantigen-specific T cells. Science. 348:803–808. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Manuel M, Tredan O, Bachelot T, Clapisson
G, Courtier A, Parmentier G, Rabeony T, Grives A, Perez S, Mouret
JF, et al: Lymphopenia combined with low TCR diversity (divpenia)
predicts poor overall survival in metastatic breast cancer
patients. Oncoimmunology. 1:432–440. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan Q, Zhang C, Yang W, Liu Y, Heyilimu P,
Feng D, Xing L, Ke Y and Lu Z: Isolation of T cell receptor
specifically reactive with autologous tumour cells from
tumour-infiltrating lymphocytes and construction of T cell receptor
engineered T cells for esophageal squamous cell carcinoma. J
Immunother Cancer. 7:2322019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thorsson V, Gibbs LD, Brown DS, Wolf D,
Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy
JA, et al: The Immune landscape of cancer. Immunity.
48:812–830.e14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saitoh H, Hirokawa M, Fujishima N,
Ichikawa Y, Kawabata Y, Miura I, Miura AB, Matsutani T, Suzuki R
and Sawada K: The presence and longevity of peripherally expanded
donor-derived TCRalphabeta+ mature T lymphocyte clones after
allogeneic bone marrow transplantation for adult myeloid leukemias.
Leukemia. 17:1626–1635. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsutani T, Yoshioka T, Tsuruta Y,
Shimamoto T, Ohyashiki JH, Suzuki R and Ohyashiki K: Determination
of T-cell receptors of clonal CD8-positive T-cells in
myelodysplastic syndrome with erythroid hypoplasia. Leuk Res.
27:305–312. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsutani T, Ohashi Y, Yoshioka T, Tsuruta
Y, Doi H, Satomi S and Suzuki R: Skew in T-cell receptor usage and
clonal T-cell expansion in patients with chronic rejection of
transplanted kidneys. Transplantation. 75:398–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
